NAMENDA
Live / Registered — Registered and renewed (as of 02 Jul 2024)
What this means for you
Registered since 18 May 2004. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 May 2024).
Record
- Serial number
- 78093238
- Registration number
- 2843824
- Mark type
- Word mark
- Filed
- 14 Nov 2001
- Published for opposition
- 12 Nov 2002
- Registered
- 18 May 2004
- Next maintenance due
- 18 May 2024
- Attorney of record
- G. Patrick SAGE
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neuropathic pain, diabetic neuropathy, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent
Owner
- MERZ PHARMA GMBH & CO. KGAA, FRANKFURT AM MAIN, DE
- Forest Laboratories, Inc., New York, NY, US
- Forest Laboratories, Inc., New York, NY, US
- Forest Laboratories, Inc., New York, NY, US
Prosecution history
- 02 Jul 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 02 Jul 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 02 Jul 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 02 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Apr 2024 — TEAS SECTION 8 & 9 RECEIVED
- 09 Jun 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
- 09 Jun 2014 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 09 Jun 2014 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 09 Jun 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 May 2014 — TEAS SECTION 8 & 9 RECEIVED
- 24 Nov 2009 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 24 Nov 2009 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Nov 2009 — TEAS SECTION 8 & 15 RECEIVED
- 11 Jul 2006 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 Jul 2006 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED